Davis Polk Advises Roche on Its Offer to Acquire Illumina

Davis Polk is advising Roche on its proposal to acquire Illumina, Inc. for $44.50 per share in cash, or approximately $5.7 billion on a fully diluted basis. In addition, Roche will nominate a slate of highly qualified, independent candidates for election to Illumina’s board of directors and propose certain other matters for the consideration of Illumina’s shareholders at Illumina’s 2012 annual meeting, which, if adopted, would result in Roche-nominated directors comprising a majority of the Illumina board. Roche’s offer will be subject to customary conditions, including the tender of a majority of Illumina’s shares of common stock.

More >>

Tags:  Davis Polk & Wardwell LLP | New York

Dechert Represents Celgene in Acquisition of Avila Therapeutics

Celgene Corporation (NASDAQ: CELG), a New-Jersey-based corporation and Avila Therapeutics, Inc., a Massachusetts-based privately held biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, today announced a definitive merger agreement under which Celgene Corporation will acquire Avila Therapeutics, Inc.

More >>

Tags:  Dechert LLP

Orrick Advises San Diego Gas & Electric in Major Wind Power Investment

In a first-of-its-kind transaction, a San Francisco and Washington, D.C., team recently advised San Diego Gas & Electric (SDG&E) in its $285 million investment in the Rim Rock wind power project in northern Montana.  This is the first time that a California regulated utility has invested in a renewable energy project in order to use the tax benefits of ownership to reduce the price it pays for energy.

More >>

Tags:  Orrick, Herrington & Sutcliffe LLP

Weil – AmSafe Global Holdings to be Acquired by TransDigm for $750 Million

AmSafe Global Holdings, Inc., a world leading supplier of innovative, highly engineered and proprietary safety and restraint equipment used primarily in the global aerospace industry, announced that it has reached agreement to be purchased by TransDigm Group Incorporated for $750 million. Global firm Weil, Gotshal & Manges was counsel to AmSafe on the all-cash transaction, which is expected to close before the end of the second quarter of fiscal 2012, subject to regulatory approvals and customary closing conditions.

More >>

Tags:  Weil, Gotshal & Manges, LLP